Looking Back at the Trump Administration’s Impact on the Life Science Industry
Four years ago, Erik Clausen, CG Life Managing Partner, predicted the Trump Administration’s impact on the Life Sciences and it’s marketers (like us). Find if he was right in this blog!Read More
Intellectual Property Rights Fuel Innovation, But What’s Their Place In A Public Health Crisis?
COVID-19 has changed innumerable things including intellectual property conversations. See how a potential 2021 shift in IP ideology compares to a similar public health crisis in 2001.Read More
Magnify Your Marketing and Public Relations with a Strategic Editorial Calendar
The media landscape is extremely noisy, yet your job is to figure out how to generate visibility for your organization. So, how do you set your company up for maximum media coverage in the upcoming year? Start by building an editorial calendar for your organization with help from this blog!Read More
How to Restore Trust in Science and Address Public Fear of the Unknown
The growing role of science and technology in public life has created a scenario where the scientific and medical communities can not afford to ignore public distrust. This post explores the causes of distrust in scientific institutions and offers commitments companies can make to restore that trust.Read More
Forecasting Life Science and Healthcare Sales in a Post-Pandemic World
To better understand how how life science and healthcare sales have been affected by our new “normal,” we sat down with a number of sales managers to hear their predictions for the long-term outlook of their efforts. Within, read about some key trends and adaptation insights collected from our conversations.Read More
CG Life Makes MM&M Top 100 Healthcare Agencies: Time for Matching Tattoos?
We made MM&M’s top 100 North American Healthcare agencies of 2020! Time for the team to get some matching tattoos!Read More